Curaleaf Receives Clinical Registrant Designation by the Pennsylvania Department of Health
(WorldNews Health)

National Cannabis Leader will be Part of State`s First-in-the-Nation Research Program and Help Shape the Future of Medical Cannabis Treatment PHILADELPHIA, Feb. 21, 2020 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (`Curaleaf` or the `Company`), a leading vertically integrated cannabis operator in the United States, has been approved as a Clinical Registrant in Pennsylvania by the Commonwealth`s Department of Health, Office of Medical Marijuana. Under this designation, the Company will be permitted to open a cultivation and processing facility and up to six dispensaries, under the Commonwealth`s medical marijuana research program. As a Clinical Registrant, Curaleaf will...